NCOA7-AS1

Across TCGA pan-cancer cohorts, NCOA7-AS1 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated NCOA7-AS1 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher NCOA7-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated NCOA7-AS1 expression acts as an unfavorable survival marker, although some lineages such as MESO and UCS show a favorable association.

CHOL, CESC, and STAD are the cancer types where NCOA7-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	IV	0.024	0.732	.014	36	view →
CESC	OS	Tertile	IV	0.198	0.635	.006	36	view →
STAD	DFS	Quartile	All	0.592	0.847	.008	29	view →
PRAD	DFS	Tertile	All	0.889	0.942	.016	18	view →
SKCM	OS	Tertile	IV	0.192	0.571	.006	16	view →
PAAD	DFS	Tertile	All	0.202	0.415	.011	12	view →
KIRC	OS	Quartile	II,III,IV	0.599	0.707	.018	8	view →
MESO	OS	Median	IV	0.718	0.399	.020	6	view →
UCS	DFS	Tertile	II,III,IV	0.749	0.366	.037	6	view →
READ	OS	Tertile	II,III,IV	1.000	0.581	.037	6	view →
LGG	DFS	Tertile	All	0.684	0.858	.024	3	view →
THCA	DFS	Tertile	IV	1.000	0.718	.034	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

NCOA7-AS1–CHOL (OS)

Open the CHOL breakdown →